Guidance Document - Comparative Bioavailability Standards: Formulations Used for Systemic Effects (French, HTML)

View metadata and access the original French HTML file: Guidance Document - Comparative Bioavailability Standards: Formulations Used for Systemic Effects.

Format

HTML

Access

file-only

Publisher-reported update

2021-06-01

To ensure that sponsors of new drug submissions have the information necessary to comply with Sections C.08.002(2)(h), C.08.002.1(2)(c)(ii) and C.08.003(3) of the Food and Drug Regulations with respect to comparative bioavailability and comparative pharmacodynamic studies used in support of the safety and efficacy of a drug.

Access original file